Somatostatin Receptor Expression in Breast Cancer
Author Information
Author(s): AA Evans, T Crook, SAM Laws, AC Gough, GT RoyIe, JN Primrose
Primary Institution: Academic Department of Surgery, Southampton General Hospital
Hypothesis
The study investigates the expression of somatostatin receptor subtypes in human breast cancer tissue.
Conclusion
SSTR2 is ubiquitously expressed in breast cancer, while SSTR5 is expressed in about one-third of tumors, suggesting potential therapeutic applications for somatostatin analogues.
Supporting Evidence
- SSTR2 was expressed in 98% of breast tumors analyzed.
- Approximately one-third of tumors expressed SSTR5.
- Only one tumor out of 51 was SSTR2 negative on RT-PCR.
Takeaway
This study looked at how certain receptors related to somatostatin are found in breast cancer tissues, which could help in treating the disease.
Methodology
The expression of somatostatin receptor subtypes was analyzed using reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH).
Limitations
The detection of mRNA does not necessarily imply the presence of functional cell-surface receptors.
Participant Demographics
77.5% of women were post-menopausal, with a mean age of 60 years.
Want to read the original?
Access the complete publication on the publisher's website